相关实验视频
Updated: May 13, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
超越试错:一个数学模型扎DLBCL异质性向优化组合疗法优化
Jordan S Goldstein1, Nick A Phillips1, Ash A Alizadeh1
1Division of Oncology, Stanford University, Stanford, California.
一个新的数学模型通过考虑患者的可变性来预测分散型大B细胞淋巴瘤组合疗法的结果. 这种框架可以优化临床试验,加速淋巴瘤治疗的开发.
科学领域:
- 血液学 血液学 血液学
- 数学生物学 数学生物学
- 在瘤学瘤学.
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种常见的非霍奇金淋巴瘤,治疗反应可变.
- 第一线组合疗法是标准的,但预测个体患者的结果仍然具有挑战性.
- 患者间和患者内异质性显著影响治疗疗效.
研究的目的:
- 介绍一个新的数学模型来预测DLBCL的结果.
- 将患者间和患者内异质性纳入治疗结果预测中.
- 为优化DLBCL的第一线组合疗法提供一个框架.
主要方法:
- 开发一个定量数学框架.
- 包括代表患者间变异性的参数.
- 包括代表患者内变异性的参数.
主要成果:
- 该模型准确地预测了DLBCL的第一线组合疗法的结果.
- 该框架量化了患者异质性对治疗反应的影响.
- 证明了在临床环境中提高预测准确性的潜力.
结论:
- 提出的数学模型为预测DLBCL治疗结果提供了一个强大的工具.
- 这种定量框架有助于优化DLBCL治疗的临床试验设计.
- 该模型有可能加速淋巴瘤治疗的临床开发和个性化.
更多相关视频
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
05:29A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
相关概念视频
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Analysis of Population Pharmacokinetic Data
Three-Compartment Open Model